Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

China

Anhui Provincial Cancer Hospital, Hefei, Anhui

Beiing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality

The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University), Chongqing, Chongqing Municipality

Gansu Provincial Maternity and Child-care Hospital, Lanzhou, Gansu

The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi